Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evariant was a U.S. healthcare technology company focused on CRM, patient acquisition, physician alignment, and analytics for hospitals and health systems. Rather than developing therapeutics, it sold a SaaS-based engagement and data platform designed to help provider organizations find, guide, and retain patients, improve service line growth, and optimize physician network utilization. The company was known for its "Patients for Life Platform" and for combining consumer and physician engagement tools with healthcare-specific data intelligence. Evariant was acquired by Healthgrades in January 2020 and no longer appears to operate as an independent active company. Its business fit within healthcare commercial intelligence and provider growth software rather than biotech or pharmaceutical R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evariant.